Larvol Delta - shibio-Doses-First-Patient-in-ANDECAL-study-a-Phase-23-Trial-of-Andecaliximab-for-Treatment-of-Fibrodysplasia-Ossicans-Progressiva-FOP

andecaliximab (GS-5745) - Gilead

https://www.businesswire.com/news/home/20250123107374/en/%C4%81shibio-Doses-First-Patient-in-ANDECAL-study-a-Phase-23-Trial-of-Andecaliximab-for-Treatment-of-Fibrodysplasia-Ossificans-Progressiva-FOP

Jan 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next